| pubmed-article:11451561 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11451561 | lifeskim:mentions | umls-concept:C0003018 | lld:lifeskim |
| pubmed-article:11451561 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
| pubmed-article:11451561 | lifeskim:mentions | umls-concept:C0004358 | lld:lifeskim |
| pubmed-article:11451561 | lifeskim:mentions | umls-concept:C0162739 | lld:lifeskim |
| pubmed-article:11451561 | lifeskim:mentions | umls-concept:C1135241 | lld:lifeskim |
| pubmed-article:11451561 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:11451561 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
| pubmed-article:11451561 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:11451561 | pubmed:dateCreated | 2001-7-13 | lld:pubmed |
| pubmed-article:11451561 | pubmed:abstractText | We present a 24-year-old woman with a twin pregnancy who was with a typical HELLP syndrome at the 18th week of pregnancy. One fetus was dead, while the other was severely growth retarded. Our patient had agonistic autoantibodies directed at the angiotensin AT(1)-receptor. Termination of the pregnancy proved necessary. This report is the first to our knowledge associating HELLP syndrome with angiotensin AT(1)-receptor antibodies. Since the antibodies may have a pathogenic significance, their removal could permit the prolongation of pregnancy in preeclamptic and HELLP syndrome patients. | lld:pubmed |
| pubmed-article:11451561 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11451561 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11451561 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11451561 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11451561 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11451561 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11451561 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11451561 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11451561 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11451561 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:11451561 | pubmed:issn | 0301-2115 | lld:pubmed |
| pubmed-article:11451561 | pubmed:author | pubmed-author:FischerTT | lld:pubmed |
| pubmed-article:11451561 | pubmed:author | pubmed-author:WallukatGG | lld:pubmed |
| pubmed-article:11451561 | pubmed:author | pubmed-author:SchneiderM... | lld:pubmed |
| pubmed-article:11451561 | pubmed:author | pubmed-author:HomuthVV | lld:pubmed |
| pubmed-article:11451561 | pubmed:author | pubmed-author:MunzWW | lld:pubmed |
| pubmed-article:11451561 | pubmed:author | pubmed-author:SchlembachDD | lld:pubmed |
| pubmed-article:11451561 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11451561 | pubmed:volume | 97 | lld:pubmed |
| pubmed-article:11451561 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11451561 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11451561 | pubmed:pagination | 255-7 | lld:pubmed |
| pubmed-article:11451561 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:11451561 | pubmed:meshHeading | pubmed-meshheading:11451561... | lld:pubmed |
| pubmed-article:11451561 | pubmed:meshHeading | pubmed-meshheading:11451561... | lld:pubmed |
| pubmed-article:11451561 | pubmed:meshHeading | pubmed-meshheading:11451561... | lld:pubmed |
| pubmed-article:11451561 | pubmed:meshHeading | pubmed-meshheading:11451561... | lld:pubmed |
| pubmed-article:11451561 | pubmed:meshHeading | pubmed-meshheading:11451561... | lld:pubmed |
| pubmed-article:11451561 | pubmed:meshHeading | pubmed-meshheading:11451561... | lld:pubmed |
| pubmed-article:11451561 | pubmed:meshHeading | pubmed-meshheading:11451561... | lld:pubmed |
| pubmed-article:11451561 | pubmed:meshHeading | pubmed-meshheading:11451561... | lld:pubmed |
| pubmed-article:11451561 | pubmed:meshHeading | pubmed-meshheading:11451561... | lld:pubmed |
| pubmed-article:11451561 | pubmed:meshHeading | pubmed-meshheading:11451561... | lld:pubmed |
| pubmed-article:11451561 | pubmed:meshHeading | pubmed-meshheading:11451561... | lld:pubmed |
| pubmed-article:11451561 | pubmed:meshHeading | pubmed-meshheading:11451561... | lld:pubmed |
| pubmed-article:11451561 | pubmed:meshHeading | pubmed-meshheading:11451561... | lld:pubmed |
| pubmed-article:11451561 | pubmed:meshHeading | pubmed-meshheading:11451561... | lld:pubmed |
| pubmed-article:11451561 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11451561 | pubmed:articleTitle | HELLP syndrome in the 18th week of gestation in association with elevated angiotensin AT(1)-receptor autoantibodies. | lld:pubmed |
| pubmed-article:11451561 | pubmed:affiliation | Department of Gynecology and Obstetrics, University of Erlangen/Nuremberg, Universitaetsstrasse 21, D-91054, Erlangen, Germany. | lld:pubmed |
| pubmed-article:11451561 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11451561 | pubmed:publicationType | Case Reports | lld:pubmed |
